Agentix Corp. (AGTX)
OTCMKTS · Delayed Price · Currency is USD
0.041942
+0.0048 (13.05%)
May 5, 2026, 3:21 PM EST
Agentix Market Cap
Agentix has a market cap or net worth of $1.49 million as of May 6, 2026. Its market cap has decreased by -93.52% in one year.
Market Cap
1.49M
Enterprise Value
1.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since June 10, 2020, Agentix's market cap has decreased from 11.57M to 1.49M, a decrease of -87.15%. That is a compound annual growth rate of -29.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 1.49M | -1.07% |
| Dec 31, 2025 | 1.50M | -78.87% |
| Dec 30, 2024 | 7.11M | 472.50% |
| Dec 14, 2023 | 1.24M | -81.27% |
| Dec 29, 2022 | 6.63M | -62.19% |
| Dec 29, 2021 | 17.54M | 1.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZyVersa Therapeutics | 1.78M |
| Clearside Biomedical | 1.65M |
| Innovation Pharmaceuticals | 1.59M |
| International Stem Cell | 1.56M |
| Iterum Therapeutics | 1.50M |
| inTerra Resources | 1.47M |
| Neon Bloom | 1.46M |
| Protagenic Therapeutics | 1.45M |